ULK1 and cancer: In summary, these studies unveil ULK1 as a novel therapeutic target for HCC (Liu et al., 2020) and indicate that targeting ULK1, in combination with other anti-cancer therapies, may be a promising interventional strategy for the treatment of HCC (Wang et al., 2018).